No CrossRef data available.
Article contents
Comparison of insight in bipolar disorder with and without co-morbid substance use disorders
Published online by Cambridge University Press: 23 March 2020
Abstract
Compare the level of insight in bipolar disorder (BD) with and without substance use disorders (SUD).
Case-control study during a period of six months from July 2015 to December 2015. One hundred euthymic patients with BD (type I, II or unspecified) were recruited in the department of psychiatry C Razi Hospital, during their follow-up. Two groups were individualized by the presence or not of SUD co-morbidity. We evaluated and compared insight with Birchwood IS scale (with its three sub-scales),
The mean age was 40.6 years (±16.4). The sex ratio was 2. Sixty-six percent of patients were diagnosed with bipolar disorder type 1 and type 2 bipolar disorder remains.
There is no statistically significant difference between bipolar with and without SUD in terms of quality of insight.
As for the subscales, bipolar patients with comorbid SUD had lower scores of awareness of any symptoms, whereas there was no significant difference regarding the awareness of illness and the need for treatment between the two populations.
Co-morbid SUD can affect the quality of insight in individuals with BD. Patients with this co-morbidity should be targeted for intensive psycho-educational measures and psychotherapeutic interventions focused on the improvement of insight.
The authors have not supplied their declaration of competing interest.
- Type
- e-Poster viewing: Comorbidity/dual pathologies
- Information
- European Psychiatry , Volume 41 , Issue S1: Abstract of the 25th European Congress of Psychiatry , April 2017 , pp. S466
- Copyright
- Copyright © European Psychiatric Association 2017
Comments
No Comments have been published for this article.